August 1, 2018 10:06 AM EDT

Moderna's Ted Ashburn jumps to the helm at Oncorus; Arrowhead pockets $10M as Amgen doses first patient with its cardio drug

John Carroll

Editor & Founder

→ Oncorus, a Cambridge, MA-based biotech focused on oncolytic viruses, has snagged Moderna’s chief of oncology development for the helm. Ted Ashburn is taking …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Moderna's Ted Ashburn jumps to the helm at Oncorus; Arrowhead pockets $10M as Amgen doses first patient with its cardio drug

John Carroll

Editor & Founder

Sign up to read this article for free.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

FDA inspectors discover trucks carrying torn-up records leaving Indian generics factory

Aligos’ trial for oral MASH treatment succeeds, but placebo group shows odd trend

Lasker Award goes to three scientists who pioneered research behind GLP-1 drugs

Roche outlines commercial manufacturing strategy for GLP-1/GIP assets

Exclusive: Flagship-backed Valo Health loses interim CEO ahead of key Phase 2 readout

Breaking down silos with a new quantitative approach to drug development

Mod­er­na's Ted Ash­burn jumps to the helm at On­corus; Ar­row­head pock­ets $10M as Am­gen dos­es first pa­tient with its car­dio drug

Editor & Founder

Sign up to read this article for free.

Viridian Therapeutics

Waltham, MA, USA

Moderna's Ted Ashburn jumps to the helm at Oncorus; Arrowhead pockets $10M as Amgen doses first patient with its cardio drug